Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00806039
NCT00806039
Unknown
Not Applicable

Impact of EArly Renal Involvement on the Developement of Severe In-hospital Renal Failure

Saint Louis VA Medical Center1 site in 1 country300 target enrollmentDecember 2008
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsKidney Failure, AcuteRenal Insufficiency, AcuteKidney FailureRenal Insufficiency

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Kidney Failure, Acute
Sponsor
Saint Louis VA Medical Center
Enrollment
300
Locations
1
Primary Endpoint
Severe renal Failure
Last Updated
16 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The purpose of this study is to determine whether renal team involvement early at the onset of kidney injury will prevent further developement of more severe renal failure and worse hospitalization outcomes.

Registry
clinicaltrials.gov
Start Date
December 2008
End Date
July 2009
Last Updated
16 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Saint Louis VA Medical Center

Eligibility Criteria

Inclusion Criteria

  • •Hospitalized, elevation in creatinine meeting definition

Exclusion Criteria

  • •CDK5, ESRD,solid organ transplant

Outcomes

Primary Outcomes

Severe renal Failure

Time Frame: 10 days

Secondary Outcomes

  • Composite outcome morbidity mortality(hospitalization)

Study Sites (1)

Loading locations...

Similar Trials

Recruiting
Not Applicable
The role of early dialysis in the evolution of patients with COVID19Coronavirus infection, unspecifiedAcute renal failureB34.2
RBR-3rdhgmDepartamento de Clínica Médica da Faculdade de Medicina de Botucatu
Recruiting
Not Applicable
THE KIMONO-STUDY.- Glomerular hyperfiltration- Solitary functioning kidney- Congenital Anomalies of the Kidney and Urinary Tract- Children- Chronic Kidney Disease- Hypertension- Proteinuria- Genetics
NL-OMON23298VU University Medical Center. Amsterdam, The Netherlands.150
Completed
Phase 1
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney DiseaseHealthy SubjectsPharmacokinetics of ASP8232Pharmacodynamics of ASP8232Chronic Kidney Disease (CKD)Type 2 Diabetes Mellitus (T2DM)
NCT02218099Astellas Pharma Europe B.V.55
Completed
Not Applicable
Acute Kidney Injury in Premature InfantsAcute Kidney Injury
NCT00573079University of Alabama at Birmingham237
Completed
Phase 1
Renal Impairment Study of Empagliflozin (BI10773) in Japanese Patients With Type 2 DiabetesDiabetes Mellitus, Type 2
NCT01581658Boehringer Ingelheim32